Found: 6
Select item for more details and to access through your institution.
Neuropeptide Y is elevated in heart failure and is an independent predictor of outcomes.
- Published in:
- European Journal of Heart Failure, 2024, v. 26, n. 1, p. 107, doi. 10.1002/ejhf.3085
- By:
- Publication type:
- Article
Incremental prognostic value of biomarkers in PARADIGM‐HF.
- Published in:
- European Journal of Heart Failure, 2023, v. 25, n. 8, p. 1406, doi. 10.1002/ejhf.2887
- By:
- Publication type:
- Article
Reply to 'Sodium–glucose cotransporter 2 inhibitor treatment lowers serum uric acid in patients with heart failure with reduced ejection fraction – lessons from clinical trials'.
- Published in:
- European Journal of Heart Failure, 2022, v. 24, n. 10, p. 1994, doi. 10.1002/ejhf.2686
- By:
- Publication type:
- Article
Dapagliflozin reduces uric acid concentration, an independent predictor of adverse outcomes in DAPA‐HF.
- Published in:
- European Journal of Heart Failure, 2022, v. 24, n. 6, p. 1066, doi. 10.1002/ejhf.2433
- By:
- Publication type:
- Article
Heart failure with preserved ejection fraction, red cell distribution width, and sacubitril/valsartan.
- Published in:
- ESC Heart Failure, 2024, v. 11, n. 1, p. 65, doi. 10.1002/ehf2.14558
- By:
- Publication type:
- Article
ACE-2 Downregulation and Incidence of Severe Acute Respiratory Syndrome-Coronavirus-2 (SARS-CoV-2) Infection.
- Published in:
- American Journal of Hypertension, 2021, v. 34, n. 4, p. 426, doi. 10.1093/ajh/hpaa191
- By:
- Publication type:
- Article